Mutations in the WNT/beta-catenin pathway are present in the majority of all sporadic colorectal cancers (CRCs). and histone deacetylase inhibitors induce apoptosis in CRC cells with such mutations. This apoptosis is counteracted by (1) the signaling heterogeneity of CRC cell populations. and (2) the survival pathways induced by mitogens secreted from apoptotic cells. https://megavitamines.shop/product-category/shampoo/